Reactivation of Latent Toxoplasmosis in a Schizophrenia Patient: A Case Report

被引:0
作者
Wahid, Wathiqah [1 ]
Zahariluddin, Anis Safirah Mohammad [1 ]
Kadir, Zuri Shahidii [2 ]
Sharip, Shalisah [2 ]
Idris, Zulkarnain Md [1 ]
Osman, Emelia [1 ]
机构
[1] Univ Kebangsaan Malaysia, Dept Parasitol & Med Entomol, Fac Med, Kuala Lumpur 56000, Malaysia
[2] Univ Kebangsaan Malaysia, Dept Psychiat, Fac Med, Kuala Lumpur 56000, Malaysia
关键词
Toxoplasmosis; Schizophrenia; Reactivated; Serology; BIPOLAR DISORDER; GONDII; DRUGS; RISK; IGG;
D O I
暂无
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Schizophrenia is a serious mental disorder characterized by chronic relapsing episodes of psychosis. The disease is multifactorial, where infections, genetic vulnerability and environmental factors are involved in the development of the illness. Toxoplasma gondii is one of the parasites that has long been known associated with schizophrenia in many studies. To date, there is growing evidence of association between T. gondii infections and schizophrenia. Herein we report a rare case of reactivated toxoplasmosis in a schizophrenia individual. This patient was incidentally diagnosed with reactivated T. gondii infection. He denied any symptoms of toxoplasmosis but experienced a mild psychiatric auditory hallucination. Serology test for T. gondii immunoglobulin antibodies measured a high positive IgG titer (135.9 IU/ml) and negative for IgM. Interestingly, nested PCR exhibited a positive result for the type I strain of T. gondii dense granular (GRA) 7 gene (GRA7). This case highlights the detection of probable reactivation of toxoplasmosis in an immunocompetent schizophrenic patient without psychiatric treatment-resistant and remains asymptomatic for toxoplasmosis. Both serology and molecular tools have been a helpful aid in establishing the diagnosis. Nonetheless, early detection as in this case may aid the patient management in the future.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 18 条
  • [1] Immunodiagnosis and molecular validation of Toxoplasma gondii-recombinant dense granular (GRA) 7 protein for the detection of toxoplasmosis in patients with cancer
    Arab-Mazar, Zahra
    Fallahi, Shirzad
    Koochaki, Ameneh
    Haghighi, Ali
    Tabaei, Seyyed Javad Seyyed
    [J]. MICROBIOLOGICAL RESEARCH, 2016, 183 : 53 - 59
  • [2] Further Evidence of Infectious Insults in the Pathogenesis and Pathophysiology of Schizophrenia
    Brown, Alan S.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (08) : 764 - 766
  • [3] Emelia O, 2012, TROP BIOMED, V29, P151
  • [4] Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study
    Flegr, J
    Havlicek, J
    Kodym, P
    Maly, M
    Smahel, Z
    [J]. BMC INFECTIOUS DISEASES, 2002, 2 (1)
  • [5] Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate
    Fond, Guillaume
    Macgregor, Alexandra
    Tamouza, Ryad
    Hamdani, Nora
    Meary, Alexandre
    Leboyer, Marion
    Dubremetz, Jean-Francois
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2014, 264 (02) : 179 - 183
  • [6] The potential risk of toxoplasmosis for traffic accidents: A systematic review and meta-analysis
    Gohardehi, Shaban
    Sharif, Mehdi
    Sarvi, Shahabeddin
    Moosazadeh, Mahmood
    Alizadeh-Navaei, Reza
    Hosseini, Seyed Abdollah
    Amouei, Afsaneh
    Pagheh, Abdolsattar
    Sadeghi, Mitra
    Daryani, Ahmad
    [J]. EXPERIMENTAL PARASITOLOGY, 2018, 191 : 19 - 24
  • [7] Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice
    Goodwin, David G.
    Strobl, Jeannine
    Mitchell, Sheila M.
    Zajac, Anne M.
    Lindsay, David S.
    [J]. JOURNAL OF PARASITOLOGY, 2008, 94 (02) : 555 - 557
  • [8] Evaluation of Five Antischizophrenic Agents Against Toxoplasma gondii in Human Cell Cultures
    Goodwin, David G.
    Strobl, Jeannine S.
    Lindsay, David S.
    [J]. JOURNAL OF PARASITOLOGY, 2011, 97 (01) : 148 - 151
  • [9] Israelski D M, 1993, Curr Clin Top Infect Dis, V13, P322
  • [10] Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii
    Jones-Brando, L
    Torrey, EF
    Yolken, R
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 62 (03) : 237 - 244